Gene: AVEN
Official Full Name: apoptosis and caspase activation inhibitorprovided by HGNC
Gene Summary: Involved in negative regulation of apoptotic process. Located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19521 | AVEN Knockout cell line (HeLa) | Human | AVEN | 1:3~1:6 | Negative | Online Inquiry |
KO19522 | AVEN Knockout cell line (HCT 116) | Human | AVEN | 1:2~1:4 | Negative | Online Inquiry |
KO19523 | AVEN Knockout cell line (HEK293) | Human | AVEN | 1:3~1:6 | Negative | Online Inquiry |
KO19524 | AVEN Knockout cell line (A549) | Human | AVEN | 1:3~1:4 | Negative | Online Inquiry |
AVEN Gene Knockout Cell Lines are specialized cell models engineered to selectively disrupt the expression of the AVEN gene, which is involved in critical cellular processes such as apoptosis and stress response. These knockout cell lines serve as essential tools for researchers aiming to dissect the roles of AVEN in various biological contexts, including cancer biology and neurodegenerative diseases. By utilizing CRISPR-Cas9 technology, these cell lines provide a precise mechanism for the targeted mutation of the AVEN gene, enabling detailed analysis of gene function and its downstream effects.
The primary function of AVEN Gene Knockout Cell Lines is to facilitate the study of gene-related pathways by comparing phenotypic and molecular outcomes between knockout and wild-type cells. The disruption of AVEN influences cellular viability, proliferation, and response to stressors, making these models invaluable for exploring mechanisms of disease progression and potential therapeutic targets. In both research and clinical settings, they allow for the evaluation of novel compounds or genetic interventions aimed at modulating AVEN activity, thereby providing insights into cancer therapeutics and regenerative medicine.
One significant advantage of our AVEN Gene Knockout Cell Lines is their reliability and reproducibility. Unlike other methods that may introduce non-specific mutations, our precision knockout approach ensures that researchers are studying the direct effects of the AVEN gene specifically. Additionally, these cell lines come well-characterized and validated, saving researchers time and reducing variability in experimental outcomes.
For researchers and clinicians, the ability to manipulate gene expression with high specificity opens new avenues for functional genomics and therapeutic development. These cell lines will empower users to unlock new knowledge about gene functions and regulatory networks that govern critical biological processes.
Our company specializes in the development of innovative biological tools backed by rigorous scientific research and expertise. With a commitment to quality and precision, we strive to equip researchers and clinicians with the resources necessary to advance their scientific endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.